JPRN-UMIN000007171已完成未知
The combined therapy with Olmesartan and Azelnidipin in the hypertensive patients with sleep apnea syndrome (SAS) - The combined therapy with Olmesartan and Azelnidipin in the hypertensive patients with sleep apnea syndrome (SAS)
Department of Internal Medicine, Graduate School of Medical Science, Kanazawa University0 个研究点目标入组 100 人开始时间: 2012年2月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) The patient who is taking azelnidipine or amlodipine 2) The patient who has critical liver disease. (AST or ALT is 100 or more IU/L) 3) The patient who has a critical renal disease (the patient under dialysis enforcement is included). (more than BUN 25mg/dL or more than serum creatinine 2.0mg/dL) 4) Pregnant or lactating women
研究者
相似试验
已完成
4 期
Combination Therapy of Olmesartan and Azelnidipine or Valsartan and Amlodipine in Hypertensinve Patients StudyHypertensionJPRN-UMIN000004288Hiroshima University200
已完成
不适用
Effect of co-administration of Olmesartan and Azelnidipine on vascular endothelial function in patients with atherosclerosis-prone conditions.Patients with hypertension and atherosclerosis-prone conditions.JPRN-UMIN000004479Kitasato University School of Medicine, Cardioangiology20
已完成
不适用
Randomized trial of olmesartan and azelnidipine for treatment of hypertension with chronic kidney diseasehypertension with CKDJPRN-UMIN000006920Division of Nephrology, Juntendo University100
已完成
不适用
Randomized study to compare olmesartan + azelnidipine versus valsartan + amlodipine to maximize blood pressure control and organ protectioHypertensionJPRN-UMIN000006605Kyoto Prefectural University School of Medicine50
进行中（未招募）
1 期
Tratamiento con Olmesartán + Amlodipino en pacientes diabéticos: evaluación del control de la presión sanguínea 48 horas después de la última administración (dosis omitida)EUCTR2010-018774-21-ESMENARINI INTERNATIONAL OPERATIONS LUXEMBOURG SA260